Religious Social Integration, Psychedelics, and Psychological Distress.
Journal of Psychoactive Drugs November 7, 2024 DOI: 10.1080/02791072.2024.2425021 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 458,372 |
| Population | U.S. respondents to the National Survey of Drug Use and Health (NSDUH) from 2008 to 2019 |
| Citations | 6 |
| Key findings | Among individuals with high religious salience, psychedelic use is associated with higher psychological distress, but those with both high religious salience and frequent religious attendance have the lowest distress. |
Abstract
Psychedelic use has been increasingly accepted socially and legally. However, there is a gap in understanding how religion can influence the relationship between psychedelics and mental health. This study aims to explore this relationship by examining the impact of lifetime classic psychedelic use (LCPU), religious attendance, and religious salience on monthly psychological distress, using the K6 scale. The data for this project is sourced from the National Survey of Drug Use and Health (NSDUH) from 2008 to 2019, with a sample size of 458,372. The analysis utilizes several Ordinary Least Square regression models conducted in Stata 17. The results indicate that both religion and psychedelic use are associated with lower levels of psychological distress. While increased religious salience is linked to reduced distress, this effect is weakened by psychedelic use, as higher salience is associated with higher levels of distress among individuals who have used psychedelics. However, a three-way interaction analysis reveals that individuals with high religious salience and attendance experience the lowest levels of distress.
Citations in the library
Cited by 5
- The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress Healthcare May 16, 2025
- Quantitative and qualitative influences of spiritual connection and natural imagery on perception of art in clinical psychedelic dosing settings. Scientific Reports July 21, 2025
- Exploring patterns of concurrent substance use, psychedelic dosing and intentions, and childhood trauma in psychedelic use in college aged adults Psychedelics January 18, 2026
- The medical sociological and social epidemiological psychedelics paradigm (MSSEPP) Drug Science, Policy and Law November 1, 2025
- Educational moderation of gender disparities in psychedelic health outcomes Academia Mental Health and Well-Being March 6, 2025
Cites 42
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
and 37 more in the library